Navigation Links Files for Patent on Unique Macular Degeneration Supplement

Removal of Vitamin E from High Dose Eye Vitamins Provides Safety for Certain Patients.

Huntington, NY (PRWEB) November 18, 2008 --, an industry leader in eye health supplements, announced this week the filing for a United States patent application for an eye vitamin formulated to improve macular degeneration and provide safety for people on anticoagulation therapy.

The nutritional supplement, VisiVite i-Defense E-Free Formula, is based upon the groundbreaking 2001 Age-Related Eye Disease Study (AREDS) performed by the United States National Eye Institute. That research showed for the first time that high dose nutritional supplements could prevent the progression of macular degeneration. The AREDS formula included high doses of beta-carotene, Vitamins C and E, Zinc and Copper.

However, people who take Coumadin (warfarin) are frequently advised by physicians to avoid the high doses of Vitamin E used in AREDS because of the increased risk of bruising and hemorrhages.

The Grene Vision Group based in Southeastern Kansas and consisting of 42 optometrists and ophthalmologists in 20 offices, recommends VisiVite eye vitamin supplements for their patients. Spokesperson and partner, Dr. Steven Kuhl, explains, "We were impressed with the attention to quality and individualization of treatment that VisiVite supplements offer for our patients with macular degeneration. One example of this is VisiVite i-Defense E-Free Formula, which provides a customized level of nutritional therapy for our patients who cannot, for medical reasons, safely take high doses of Vitamin E."

The American Academy of Ophthalmology meeting, held earlier this month in Atlanta, Georgia, focused on the rapidly changing treatments and diagnostic tests for Age Related Macular Degeneration.

Since its introduction in early 2006, VisiVite i-Defense E-Free Formula has undergone annual sales growth of 260%, clearly fulfilling an unmet need.

VisiVite i-Defense E-Free Formula includes high dosages of Vitamin C and Zinc, the carotenoids Lutein and Zeaxanthin, Bilberry, Grapeseed Extract, and additional antioxidants.

Since 2001, is dedicated to providing customers with state of the art eye vitamins to lessen the risk of age-related macular degeneration. Their products include Macular Degeneration Vitamins and Dry Eye Relief Vitamins. For more information and up-to-the minute AMD news, visit .


Read the full story at

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. State Fund Files an 8.9 Percent Premium Increase for 2009
2. KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q
3. Genesis Pharmaceuticals Files Counter Claims
4. Mary Hall, CEO of iHealthSpot, Inc., is Awarded Membership Into Fort Lauderdale City Limits "Profiles of Excellence"
5. Corporate Parent Hospital Partners of America Files Voluntary Chapter 11 Petition; Filings do not Include any Hospital Facilities
6. New York-Based Sanders Law Firm Files Claim for Good Samaritan Beaten by New York City Police Officers
7. Allscripts Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
8. ULTCW Files Complaint Against UHW-W and Calls for Full Investigation by SEIU International
9. VirtualScopics Receives NASDAQ Delisting Notice; Company Files Appeal to Stay Delisting
10. Emageon Files Quarterly Report
11. New York-Based Sanders Law Firm Files Five Product Liability Lawsuits Against Pfizer on Behalf of Chantix™ Plaintiffs
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: